CONGRESS|#EHA2021| @H_Einsele, University Hospital Wurzburg discussed novel strategies like dual targeting CAR-T cells, Tri-specific T cell engaging Abs, drugs& combination with checkpoint blockers are opening new options for T cell redirecting strategies #mmsm, #myeloma pic.twitter.com/FjEujEVmoa
— Multiple Myeloma Hub (@MM_Hub) June 14, 2021